Phil Tennant's most recent trade in Precigen Inc was a trade of 125,000 Restricted Stock Units done . Disclosure was reported to the exchange on June 26, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Precigen Inc | Phil Tennant | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 125,000 | 125,000 | - | - | Restricted Stock Units | |
| Precigen Inc | Phil Tennant | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2025 | 250,000 | 250,000 | - | - | Option to Purchase Common Stock (Right to Buy) | |
| Precigen Inc | Phil Tennant | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2025 | 66,441 | 0 | - | - | Restricted Stock Units | |
| Precigen Inc | Phil Tennant | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2025 | 66,441 | 82,000 (0%) | 0% | - | Common Stock | |
| Precigen Inc | Phil Tennant | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.45 per share. | 16 May 2025 | 22,969 | 59,031 (0%) | 0% | 1.4 | 33,305 | Common Stock |
| Precigen Inc | Phil Tennant | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2025 | 66,441 | 66,441 | - | - | Restricted Stock Units | |
| Precigen Inc | Phil Tennant | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 25,000 | 25,000 (0%) | 0% | 0 | Common Stock | |
| Precigen Inc | Phil Tennant | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.30 per share. | 29 Jan 2025 | 9,441 | 15,559 (0%) | 0% | 1.3 | 12,273 | Common Stock |
| Precigen Inc | Phil Tennant | Chief Commercial Officer | 22 Jul 2024 | 200,000 | 200,000 | - | - | Option to Purchase Common Stock (Right to Buy) |